LAB vs PTC · rev $174.4M vs P/E 48, rev $2.74B
Standard Biotools Inc (LAB) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
LAB currently screens at market cap $317.1M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the LAB and PTC stock pages for the full models.
Not investment advice.